Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD
- PMID: 19645868
- PMCID: PMC7190194
- DOI: 10.1111/j.1440-1843.2009.01517.x
Airway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPD
Abstract
Background and objective: There are few data on the short-term natural history of airway inflammation during severe episodes of acute exacerbation of COPD (AECOPD). An observational study was performed to determine how rapidly conventional treatment improves airway inflammation in patients admitted to hospital with AECOPD.
Methods: Twenty-four consecutive patients with AECOPD were recruited and changes in sputum inflammatory indices were assessed after 2 and 4 days of treatment. The primary end-points included presence of bacteria and viruses, changes in sputum total cell counts (TCC) and polymorphonuclear leukocyte (PMN) differential counts, and levels of secretory leukocyte protease inhibitor (SLPI), IL-8 and TNF-alpha.
Results: All patients received oral corticosteroids and 17 (71%) were also treated with oral antibiotics. A bacterial or viral pathogen was isolated from 12 patients (50%), and Aspergillus fumigatus was isolated from one. A positive bacterial culture was associated with increased sputum TCC and PMN count (P < 0.05), as well as higher levels of IL-8 and TNF-alpha (P < 0.05), and a trend towards lower sputum SLPI levels (P = 0.06). Sputum PMN numbers fell by 70% within the first 48 h of admission (P < 0.05), accompanied by an increase in sputum SLPI (P < 0.001) and reductions in the levels of TNF-alpha (P < 0.005) and IL-8 (P = 0.06), with no further significant change at 4 days.
Conclusions: Conventional treatment for severe AECOPD is associated with rapid reduction of neutrophilic inflammation and improvement in anti-protease defences.
Figures
Similar articles
-
Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.BMC Infect Dis. 2009 Nov 15;9:178. doi: 10.1186/1471-2334-9-178. BMC Infect Dis. 2009. PMID: 19912665 Free PMC article.
-
Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2001 Feb;163(2):349-55. doi: 10.1164/ajrccm.163.2.2003122. Am J Respir Crit Care Med. 2001. PMID: 11179105
-
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.Eur Respir J. 2017 Mar 15;49(3):1601328. doi: 10.1183/13993003.01328-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28298400
-
Resolving Viral-Induced Secondary Bacterial Infection in COPD: A Concise Review.Front Immunol. 2018 Oct 16;9:2345. doi: 10.3389/fimmu.2018.02345. eCollection 2018. Front Immunol. 2018. PMID: 30459754 Free PMC article. Review.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
Cited by
-
The Expression of IL-6, TNF-α, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.J Immunol Res. 2017;2017:8539294. doi: 10.1155/2017/8539294. Epub 2017 Mar 2. J Immunol Res. 2017. PMID: 28352642 Free PMC article.
-
Respiratory Viral Infections in Chronic Lung Diseases.Clin Chest Med. 2017 Mar;38(1):87-96. doi: 10.1016/j.ccm.2016.11.014. Epub 2016 Dec 24. Clin Chest Med. 2017. PMID: 28159164 Free PMC article. Review.
-
Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.Med Drug Discov. 2020 Sep;7:100052. doi: 10.1016/j.medidd.2020.100052. Epub 2020 Jun 5. Med Drug Discov. 2020. PMID: 32537610 Free PMC article. Review.
-
The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.Ther Adv Respir Dis. 2016 Apr;10(2):158-74. doi: 10.1177/1753465815618113. Epub 2015 Nov 26. Ther Adv Respir Dis. 2016. PMID: 26611907 Free PMC article. Review.
-
Lung microbiology and exacerbations in COPD.Int J Chron Obstruct Pulmon Dis. 2012;7:555-69. doi: 10.2147/COPD.S28286. Epub 2012 Aug 31. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 22969296 Free PMC article. Review.
References
-
- Delmastro M, Balbi B. Acute exacerbations of COPD: is inflammation central to prevention and treatment strategies? Monaldi Arch. Chest Dis. 2002; 57: 293–6. - PubMed
-
- Aaron SD, Angel JB, Lunau M, Wright K, Fex C et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 163: 349–55. - PubMed
-
- Crooks SW, Bayley DL, Hill SL, Stockley RA. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur. Respir. J. 2000; 15: 274–80. - PubMed
-
- Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000; 117: 1638–45. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical